News
Treatment of wet age-related macular degeneration (AMD) with anti-VEGF agents currently requires a regimen of frequent…
An interview with Carl D. Regillo, MD
Conventional wisdom says that, as the population ages, degenerative diseases will increase in prevalence, meaning a …
Brian C. Joondeph, MD, MPS
On a recent Monday in clinic, a 67-year-old patient with severe hypertensive retinopathy pulled out his smartphone a…
Nancy M. Holekamp, MD
Anti-VEGF monotherapy as a management strategy to treat patients with wet age-related macular degeneration (AMD) has…
Allen C. Ho, MD
In the 30 years that I have been a practicing comprehensive ophthalmologist I have noticed that, when patients have …
Alan Mendelsohn, MD
Pharmacogenomics is the study of the interaction between drugs and the human genome, in an effort to use a rational …
Demetrios G. Vavvas, MD, PhD
Ablate-and-Replace Gene Therapy Was Successful in Mouse Model of RP
An approach to gene therapy in which a gene editi…
Aflibercept Improved DR Severity Score at 6 Months in Patients with NPDR
In a phase 3 clinical trial, 58% of patients…
